Arca Biopharma | ABIO - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 9.19B 532M 2026-03
Arca Biopharma USD 469M 17.79M 2025-12
Biogen USD 18.65B 394.9M 2026-03
Brainstorm Cell Therapeutics USD -9.98M 2.29M 2025-12
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Capricor Therapeutics USD 305.79M 221.92M 2025-12
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Cytokinetics USD -826.57M 166.94M 2026-03
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Grifols EUR 6.21B 133.12M 2025-12
Laboratory Of America USD 8.73B 108.8M 2026-03
Myriad Genetics USD 368M 4.8M 2025-12
Otsuka Holdings JPY 3.11T 74.63B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
United Therapeutics USD 7.1B 506M 2025-12